TapImmune Inc.
7Patents
6Active
7Granted
41Portfolio score
Filing activity: Jan 16, 2002 → Jul 28, 2016 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7378087B2 | Method of enhancing an immune response | Human Necessities | 24 | Expired |
| US10030252B2 | Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US9655956B2 | Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9364523B2 | Chimeric nucleic acid molecule with non-AUG translation initiation sequences | Emerging Cross-Sectional Technologies | 0 | Active |
| US7994146B2 | Method of enhancing an immune response | Human Necessities | 0 | Active |
| US7976850B2 | Pox viridae treatment | Chemistry; Metallurgy | 0 | Active |
| US9988643B2 | Chimeric nucleic acid molecules with non-AUG translation initiation sequences and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.